Clinical Trials

Calgary, Alberta T1Y 0B4

0 studies enrolling now · 1 studies all time

What they study most

Alopecia Areata

Studies at this site

• A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) — Running, not enrolling